EPS growth is an important number as it indicates the future prospects of Achieve Life Sciences. It is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but EPS has been 92.11% over the last twelve months. EPS growth is a vital measure of execution of the strategy for Achieve Life Sciences since it indicates how well the business is allocating resources to benefit shareholders.
Achieve Life Sciences is in the biotechnology industry and healthcare sector. The company CEO is Richard Alistair Balfour Stewart. Achieve Life Sciences Inc is a United States based clinical-stage biopharmaceutical company. It is focused on the development of novel next generation cancer therapeutics.
Previous Intraday Performance:
The ACHV shares had a previous change of -1.94% which opened at 1.55 and closed at 1.52. It moved to an intraday high of 1.62 and a low of 1.51.
SeekingAlpha: Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results – Earnings Call Transcript
Historical Performance:
Over the last five trading days, ACHV shares returned -7.88% and in the past 30 trading days it returned -37.45%. Over three months, it changed -53.37%. In one year it has changed -90.38% and within that year its 52-week high was 32.00 and its 52-week low was 1.51. ACHV stock is 0.66% above its 52 Week Low.
Our calculations result in a 200 day moving average of 6.80 and a 50 day moving average of 2.24. Right now, ACHV stock is trading -77.64% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
SeekingAlpha: Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results – Earnings Call Transcript
Liquidity:
The company has a market cap of $10.2m with 6.7m shares outstanding and a float of 4.1m shares. Trading volume was 71,613 shares and has experienced an average volume of 292,217 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Achieve Life Sciences was -94.32 which ended on 31st of December 2017.
Below was the last reported quarterly earnings per share:
09-30-2018: -0.71
06-30-2018: -1.82
03-31-2018: -2.40
12-31-2017: -3.20
Indicators Also to Watch:
Based on the latest filings, there is 12.50% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.
I calculated the beta to be 2.15
SeekingAlpha: Natural gas jumps as cold air descends on U.S. Midwest
Fundamental Numbers:
Based on last reported financials, the company’s return on equity is -103.41%, return on assets is -85.16% and price-to-book is 0.72.
Company Score Card:
Results are out of six:
3 : Growth Expectations Result
6 : Financial Safety Result
0 : Past Performance Result
1 : Valuation Result
0 : Dividend Safety Result
2 : Overall Result
Related Tags: Achieve Life Sciences, ACHV, Biotechnology, Healthcare
